Alyeska Investment Group, L.P. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 132 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$1,918,000
-65.8%
267,475
-32.3%
0.02%
-66.2%
Q1 2019$5,602,000
+70.9%
395,356
+63.2%
0.07%
+54.2%
Q4 2018$3,278,000
-76.4%
242,244
-61.3%
0.05%
-68.4%
Q3 2018$13,878,000
+376.6%
625,422
+252.5%
0.15%
+484.6%
Q2 2018$2,912,000177,4400.03%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$90,819,89014.58%
Eversept Partners, LP 2,644,988$11,161,8490.94%
TPG GP A, LLC 12,328,767$52,027,3970.90%
Nantahala Capital Management 2,212,757$9,337,8350.80%
Rubric Capital Management LP 4,024,500$16,983,3900.64%
Hedges Asset Management LLC 84,600$357,0120.31%
Signature Wealth Management Partners, LLC 66,666$281,3310.28%
Tejara Capital Ltd 96,672$407,9560.23%
Tranquilli Financial Advisor LLC 71,414$301,3670.22%
EAM Investors, LLC 230,271$971,7440.19%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders